This is the authors' abstract. We don't add key points for this paper.
The integration of 5 G with emerging technologies, including big data, artificial intelligence (AI), machine learning (ML), and the Internet of Things (IoT), is anticipated to revolutionize the healthcare sector. By providing enhanced Mobile Broadband (eMBB), ultra-reliable low-latency communication (URLLC), and ubiquitous connectivity, 5 G is set to transform patient care through real-time communication, remote diagnostics, and tactile internet-enabled telemedicine. These advancements are expected to foster high-performance, reliable, and personalized healthcare solutions. Furthermore, the convergence of sensor technologies, AI, and ML will enhance diagnostic accuracy and support proactive, data-driven medical decision-making. Notably, AI is also emerging as a powerful tool in cancer pharmacology, facilitating early cancer detection, drug discovery, and personalized oncology through advanced predictive models and real-time analytics. AI-driven platforms can analyze complex oncological datasets to identify optimal treatment pathways and predict therapeutic responses, significantly improving outcomes for cancer patients. This report offers a comprehensive analysis of the impending 5G-enabled healthcare revolution, examining the interplay of enabling technologies, current research, and practical applications. It includes a case study on the economic benefits of 5 G in healthcare and discusses the key challenges and risks that must be addressed to fully realize its potential.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: